Barclays PLC Takeda Pharmaceutical CO LTD Put Options Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 13, 2021	SELL	$16.71 - $19.9 $1.05 Million - $1.25 Million	-62,830 Reduced 29.52%	150,000 $2.74 Million
Q2 2020 Aug 12, 2020	SELL	$14.59 - $19.5 $1.03 Million - $1.37 Million	-70,388 Reduced 24.85%	212,830 $3.82 Million
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $162,736 - $253,854	-12,499 Reduced 4.23%	283,218 $4.3 Million
Q4 2019 Feb 10, 2020	SELL	$16.88 - $20.83 $5,064 - $6,248	-300 Reduced 0.1%	295,717 $5.84 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $9,625 - $10,722	596 Added 0.2%	296,017 $5.09 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $421,364 - $520,732	25,414 Added 9.41%	295,421 $5.23 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $4.51 Million - $5.81 Million	270,007 New	270,007 $5.5 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.